UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 199

Sortiert nach

Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence

Clinical gastroenterology and hepatology, 2014-09, Vol.12 (9), p.1494-1502.e1

2014

Volltextzugriff (PDF)

Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops

Inflammatory bowel diseases, 2014-05, Vol.20 (5), p.926-935

2014

Volltextzugriff (PDF)

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial

The American journal of gastroenterology, 2018-10, Vol.113 (10), p.1516-1523

2018

Volltextzugriff (PDF)

Cutaneous Manifestations of Crohn Disease

Dermatologic clinics, 2015-07, Vol.33 (3), p.417-431

2015

Volltextzugriff (PDF)

Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease

Digestive diseases and sciences, 2018-03, Vol.63 (3), p.755-760

2018

Volltextzugriff (PDF)

Evaluation for Postoperative Recurrence of Crohn Disease

Gastroenterology clinics of North America, 2012-06, Vol.41 (2), p.303-314

2012

Volltextzugriff (PDF)

Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation

Inflammatory bowel diseases, 2016-11, Vol.22 (11), p.2665-2671

2016

Volltextzugriff (PDF)

Preventive therapy in postoperative Crohnʼs disease

Current opinion in gastroenterology, 2010-07, Vol.26 (4), p.337-343

2010

Volltextzugriff (PDF)

Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1164-1172

2013

Volltextzugriff (PDF)

Reply: To PMID 24530602

Clinical gastroenterology and hepatology, 2014-08, Vol.12 (8), p.1407-1407

2014

Volltextzugriff (PDF)

Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study

Inflammatory bowel diseases, 2015-11, Vol.21 (11), p.2576-2582

2015

Volltextzugriff (PDF)

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

Inflammatory bowel diseases, 2010-11, Vol.16 (11), p.1912-1921

2010

Volltextzugriff (PDF)

147 Does Persistent Stress Impact Quality of Life and Disease Course in Patients With IBD? A 4 Year Prospective Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-39-S-39

2015

Volltextzugriff (PDF)

Tu1251 The Financial Burden of Crohn's Disease Healthcare Expenditures: A Multi-Year Prospective Experience

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-836-S-837

2015

Volltextzugriff (PDF)

150 Demographic Predictors of High-Cost Inflammatory Bowel Disease Patients: A Prospective 5-Year Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-40-S-41

2015

Volltextzugriff (PDF)

Tu1271 An Inflammatory Bowel Disease Patient's Worst Fears: A Prospective Evaluation of Quality of Life Following Permanent Ileostomy Creation

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-843-S-844

2015

Volltextzugriff (PDF)

Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications

International journal of colorectal disease, 2014, Vol.29 (1), p.133-133

2014

Volltextzugriff (PDF)

Su1398 Prospective Analysis of Bile Acid Sequestrant Therapy in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-458-S-459

2014

Volltextzugriff (PDF)

Su1390 The Longitudinal Impact of Serotonin Reuptake Inhibitors on Quality of Life and Disease Activity in Adults With Inflammatory Bowel Disease (IBD)

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-456-S-456

2014

Volltextzugriff (PDF)

Su1345 Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4 Year Prospective Study

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-442-S-442

2014

Volltextzugriff (PDF)

Tu1232 The Value of Tertiary Referral Crohn's Disease Care: Targeting “Superutilizer” Patients for Reduction of Healthcare Utilization

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-829-S-829

2015

Volltextzugriff (PDF)

Su1314 Prevalence and Characteristics of Anemia in a Large U.S. Inflammatory Bowel Disease Cohort: A 5 Year Prospective Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-472-S-472

2015

Volltextzugriff (PDF)

Su1291 Low Vitamin D Status Is an Independent Predictor of Anemia in IBD: A 5-Year Prospective Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-463-S-463

2015

Volltextzugriff (PDF)

Su1233 Five Year Trends in Harvey Bradshaw Index Scores in Crohn's Disease Patient Trajectories Stratified by Change in LéMann Scores: Understanding the Utility of Both Indices

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-447-S-448

2015

Volltextzugriff (PDF)

Sa1215 Differences in Healthcare Expenditures in Crohn's Disease Lemann Score Phenotypes: A 5-Year Prospective Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-259-S-260

2015

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(158)

Publikationsform

Artikel
(169)
Buchkapitel
(28)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(199)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence

Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial

Cutaneous Manifestations of Crohn Disease

Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease

Evaluation for Postoperative Recurrence of Crohn Disease

Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation

Preventive therapy in postoperative Crohnʼs disease

Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system

Reply: To PMID 24530602

Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

147 Does Persistent Stress Impact Quality of Life and Disease Course in Patients With IBD? A 4 Year Prospective Study

Tu1251 The Financial Burden of Crohn's Disease Healthcare Expenditures: A Multi-Year Prospective Experience

150 Demographic Predictors of High-Cost Inflammatory Bowel Disease Patients: A Prospective 5-Year Study

Tu1271 An Inflammatory Bowel Disease Patient's Worst Fears: A Prospective Evaluation of Quality of Life Following Permanent Ileostomy Creation

Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications

Su1398 Prospective Analysis of Bile Acid Sequestrant Therapy in Inflammatory Bowel Disease

Su1390 The Longitudinal Impact of Serotonin Reuptake Inhibitors on Quality of Life and Disease Activity in Adults With Inflammatory Bowel Disease (IBD)

Su1345 Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4 Year Prospective Study

Tu1232 The Value of Tertiary Referral Crohn's Disease Care: Targeting “Superutilizer” Patients for Reduction of Healthcare Utilization

Su1314 Prevalence and Characteristics of Anemia in a Large U.S. Inflammatory Bowel Disease Cohort: A 5 Year Prospective Study

Su1291 Low Vitamin D Status Is an Independent Predictor of Anemia in IBD: A 5-Year Prospective Study

Su1233 Five Year Trends in Harvey Bradshaw Index Scores in Crohn's Disease Patient Trajectories Stratified by Change in LéMann Scores: Understanding the Utility of Both Indices

Sa1215 Differences in Healthcare Expenditures in Crohn's Disease Lemann Score Phenotypes: A 5-Year Prospective Study

Suchergebnisse filtern